Registry of Parkinson's disease patients in China
Official title: The Chinese Parkinson's Disease Registry
Run by Xiangya Hospital of Central South University · NCT03887663 · Data updated 2026-11-12
This study is trying to build a detailed database of people with Parkinson's disease in China to learn more about how the disease progresses and what factors might affect it.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changzhi, Hunan) |
| Status | Recruiting |
| Started | February 1, 2017 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | December 13, 2019 |
| Trial ID | NCT03887663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with Parkinson's disease according to established diagnostic criteria.
✕Probably not a fit
Patients who lack the capacity to consent to participate in the project will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chinese Parkinson's Disease Registry aims to create a comprehensive database of patients diagnosed with Parkinson's disease in China. This observational study will collect longitudinal data on various clinical features, genetic factors, and environmental influences affecting different subtypes of Parkinson's disease. By following patients over time, the study seeks to better understand the natural history of the disease and identify key milestones in its progression. Data will be gathered through routine follow-up visits, utilizing standardized neurological assessments and detailed questionnaires.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Parkinson's disease in the Chinese population, leading to improved diagnosis and treatment strategies.
How similar studies have gone: Other studies have successfully established registries for Parkinson's disease, indicating that this approach is both viable and beneficial for understanding the condition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with PD by UK Brain Bank Diagnostic Criteria and other standard criteria. Exclusion Criteria: * Lack of capacity to consent to participate in the project
Where it's running
-
Xiangya Hospital of Central South University
Changzhi, Hunan, China Recruiting
Study contacts
- Study coordinator: Qiying Sun, Ph.D
- Email: sunqiying2015@163.com
- Phone: +8615874907260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.